5 years ago
Patent-pending probiotic could disrupt Crohn's disease biofilms
"The next step for our probiotic is to conduct clinical trials to demonstrate its efficacy in diseases, such as Crohn's, ulcerative colitis and irritable bowel syndrome as well as cancer," Ghannoum said. "If the efficacy is proven, the potential impact for people suffering with these devastating conditions is extremely exciting to me as a scientist.
Continue Reading
https://www.eurekalert.org
Join the Discussion